The Roles and Responsibilities of Physicians in Patients' Decisions about Unproven Stem Cell Therapies
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jonathan Jenkins Ichikawa
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Law, Medicine & Ethics 40 (1):122-134 (2012)
Capitalizing on the hype surrounding stem cell research, numerous clinics around the world offer “stem cell therapies” for a variety of medical conditions. Despite questions about the safety and efficacy of these interventions, anecdotal evidence suggests a relatively large number of patients are traveling to receive these unproven treatments — a practice called “stem cell tourism.” Because these unproven treatments pose risks to individual patients and to legitimate translational stem cell research, stem cell tourism has generated substantial policy concern and inspired attempts to reduce these risks through the development of guidelines for patients and medical practitioners. This paper examines the roles and responsibilities of physicians in patients' home countries with respect to patients' decisions to try unproven stem cell therapies abroad. Specifically, it examines professional guidance from two organizations — the American Medical Association and the International Society for Stem Cell Research — and assesses physicians' professional and legal obligations to patients considering unproven stem cell therapies. Then, drawing on qualitative interviews conducted with patients who traveled abroad for unproven stem cell treatments, it explores the roles that physicians actually play in patients' decisions and compares these actual roles with their professional and legal responsibilities. The paper concludes with a discussion of strategies to help improve the guidance physicians provide to patients considering unproven treatments
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
Charles Murdoch & Christopher Thomas Scott (2010). Stem Cell Tourism and the Power of Hope. American Journal of Bioethics 10 (5):16-23.
Citations of this work BETA
Woody Chang, Tracy Caroline Bank & Christopher Thomas Scott (2014). Fit to Print? Media Accounts of Unproven Medical Treatments Across Time. Ajob Empirical Bioethics 5 (1):33-43.
Amy Zarzeczny & Marianne Clark (2014). Unproven Stem Cell-Based Interventions & Physicians’ Professional Obligations; a Qualitative Study with Medical Regulatory Authorities in Canada. BMC Medical Ethics 15 (1):75.
Similar books and articles
Haidan Chen & Herbert Gottweis (2013). Stem Cell Treatments in China: Rethinking the Patient Role in the Global Bio‐Economy. Bioethics 27 (4):194-207.
Cynthia B. Cohen Peter J. Cohen (2010). International Stem Cell Tourism and the Need for Effective Regulation: Part II: Developing Sound Oversight Measures and Effective Patient Support. Kennedy Institute of Ethics Journal 20 (3):207-230.
Insoo Hyun (2010). Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges. Journal of Law, Medicine & Ethics 38 (2):277-285.
Frederic Bretzner, Frederic Gilbert, Françoise Baylis & Robert M. Brownstone (2011). Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury. Cell Stem Cell 8 (5):468-475.
Cynthia B. Cohen Peter J. Cohen (2010). International Stem Cell Tourism and the Need for Effective Regulation: Part I: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype? Kennedy Institute of Ethics Journal 20 (1):pp. 27-49.
Nikolaus Knoepffler (2004). Stem Cell Research: An Ethical Evaluation of Policy Options. Kennedy Institute of Ethics Journal 14 (1):55-74.
Edna F. Einsiedel & Hannah Adamson (2012). Stem Cell Tourism and Future Stem Cell Tourists: Policy and Ethical Implications. Developing World Bioethics 12 (1):35-44.
Mark T. Brown (2009). Moral Complicity in Induced Pluripotent Stem Cell Research. Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Richard M. Doerflinger (1999). The Ethics of Funding Embryonic Stem Cell Research: A Catholic Viewpoint. Kennedy Institute of Ethics Journal 9 (2):137-150.
Carolyn Mcleod & Françoise Baylis (2007). Donating Fresh Versus Frozen Embryos to Stem Cell Research: In Whose Interests? Bioethics 21 (9):465–477.
Lawrence Burns (2009). “You Are Our Only Hope”: Trading Metaphorical “Magic Bullets” for Stem Cell “Superheroes”. Theoretical Medicine and Bioethics 30 (6):427-442.
Bernard Dickens, International Society for Stem Cell Research (ISSCR) Guidelines for the Conduct of Human Embryonic Stem Cell Research (December 2006).
David Magnus (2010). Translating Stem Cell Research: Challenges at the Research Frontier. Journal of Law, Medicine & Ethics 38 (2):267-276.
Tamra Lysaght, John Little & Ian Kerridge (2011). Marginalizing Experience: A Critical Analysis of Public Discourse Surrounding Stem Cell Research in Australia (2005–6). [REVIEW] Journal of Bioethical Inquiry 8 (2):191-202.
Added to index2012-03-28
Total downloads9 ( #439,662 of 1,925,076 )
Recent downloads (6 months)2 ( #308,563 of 1,925,076 )
How can I increase my downloads?